Literature DB >> 31452411

Dioscin attenuates Bleomycin-Induced acute lung injury via inhibiting the inflammatory response in mice.

Zhao-Li Wu1, Jia Wang2.   

Abstract

Aim: Acute lung injury (ALI), a critical illness syndrome with high morbidity and mortality, is characterized by a severe inflammatory response. Dioscin exerts protective effects against crystalline silica-induced pulmonary inflammation and fibrosis in mice. Bleomycin (BLM) is widely used to induce ALI and fibrosis in animal models. This study aims to investigate the effects of dioscin on BLM-induced ALI in mice.
Methods: C57BL/6 mice were intratracheally injected with BLM to induce ALI. Lungs and bronchoalveolar lavage fluids were then harvested on day 7 for evaluation. Changes in tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and interleukin-10 (IL-10) expression level were measured by RT-qPCR and ELISA. Protein expressions of nuclear factor-kappa B (NF-κB), cyclooxygenase-2 (COX-2), and high-mobility group box 1 (HMGB1) were measured by western blot.
Results: Dioscin protects against BLM-induced ALI by decreasing the numbers of total and inflammatory cells, lung edema, myeloperoxidase activity, and malondialdehyde content. Moreover, dioscin significantly inhibited TNF-α, IL-1β, NF-κB, COX-2, and HMGB1 levels, and upregulated IL-10 levels.
Conclusion: Our data indicate that dioscin attenuates oxidative stress, the lung inflammatory response, and acute lung injury in BLM-challenged mice.

Entities:  

Keywords:  Bleomycin; acute lung injury; dioscin; inflammation

Mesh:

Substances:

Year:  2019        PMID: 31452411     DOI: 10.1080/01902148.2019.1652370

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  3 in total

1.  Pulmonary Delivery of Hydroxychloroquine Nanostructured Lipid Carrier as a Potential Treatment of COVID-19.

Authors:  Ahmed Shaker Ali; Mohsen Geza Alrashedi; Osama Abdelhakim Aly Ahmed; Ibrahim M Ibrahim
Journal:  Polymers (Basel)       Date:  2022-06-28       Impact factor: 4.967

Review 2.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

Review 3.  Herbal Active Ingredients: Potential for the Prevention and Treatment of Acute Lung Injury.

Authors:  Wen-Ying Yu; Chun-Xiao Gao; Huan-Huan Zhang; Yue-Guo Wu; Chen-Huan Yu
Journal:  Biomed Res Int       Date:  2021-06-22       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.